An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adults

An influenza H1 hemagglutinin stem-only immunogen elicits a broadly cross-reactive B cell response in humans

(2023) Sarah F. Andrews et al.   Science Translational Medicine

Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial

(2022) Katherine V. Houser et al.   NATURE MEDICINE

Broad neutralization of H1 and H3 viruses by adjuvanted influenza HA stem vaccines in nonhuman primates

(2021) Nicole Darricarrère et al.   Science Translational Medicine

A comprehensive influenza reporter virus panel for high-throughput deep profiling of neutralizing antibodies

(2021) Adrian Creanga et al.   Nature Communications

Next-generation influenza vaccines: opportunities and challenges

(2020) Chih-Jen Wei et al.   NATURE REVIEWS DRUG DISCOVERY

Glycan repositioning of influenza hemagglutinin stem facilitates the elicitation of protective cross-group antibody responses

(2020) Seyhan Boyoglu-Barnum et al.   Nature Communications

Next-Generation Influenza Vaccines

(2020) Masaru Kanekiyo et al.   Cold Spring Harbor Perspectives in Medicine

Imprinting, immunodominance, and other impediments to generating broad influenza immunity

(2020) Matthew Knight et al.   IMMUNOLOGICAL REVIEWS

Adjuvanted H5N1 influenza vaccine enhances both cross-reactive memory B cell and strain-specific naive B cell responses in humans

(2020) Ali H. Ellebedy et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Original Antigenic Sin: How First Exposure Shapes Lifelong Anti–Influenza Virus Immune Responses

(2019) Ali Zhang et al.   JOURNAL OF IMMUNOLOGY

The 1918 influenza pandemic: 100 years of questions answered and unanswered

(2019) Jeffery K. Taubenberger et al.   Science Translational Medicine

The Quest for a Truly Universal Influenza Vaccine

(2019) Yo Han Jang et al.   Frontiers in Cellular and Infection Microbiology

DNA vaccine priming for seasonal influenza vaccine in children and adolescents 6 to 17 years of age: A phase 1 randomized clinical trial

(2018) Katherine V. Houser et al.   PLoS One

Effectiveness of influenza vaccines in preventing severe influenza illness among adults: A systematic review and meta-analysis of test-negative design case-control studies

(2017) Marc Rondy et al.   JOURNAL OF INFECTION

Is It Possible to Develop a “Universal” Influenza Virus Vaccine?

(2017) James E. Crowe   Cold Spring Harbor Perspectives in Biology

Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses

(2016) M. Gordon Joyce et al.   CELL

Hemagglutinin Stalk Immunity Reduces Influenza Virus Replication and Transmission in Ferrets

(2015) Raffael Nachbagauer et al.   JOURNAL OF VIROLOGY

Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection

(2015) Hadi M Yassine et al.   NATURE MEDICINE

Prevalence of antibodies against influenza A and B viruses in children in Germany, 2008 to 2010

(2014) A Sauerbrei et al.   Eurosurveillance

Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans

(2014) A. H. Ellebedy et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

H3N2 Influenza Virus Infection Induces Broadly Reactive Hemagglutinin Stalk Antibodies in Humans and Mice

(2013) I. Margine et al.   JOURNAL OF VIROLOGY

Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies

(2013) Masaru Kanekiyo et al.   NATURE

Mechanisms of Hemagglutinin Targeted Influenza Virus Neutralization

(2013) Boerries Brandenburg et al.   PLoS One

Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells

(2012) G.-M. Li et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Pandemic H1N1 Influenza Infection and Vaccination in Humans Induces Cross-Protective Antibodies that Target the Hemagglutinin Stem

(2012) C. A. Thomson et al.   Frontiers in Immunology

Prevalence of Antibodies against Seasonal Influenza A and B Viruses in Children in Netherlands

(2011) R. Bodewes et al.   Clinical and Vaccine Immunology

DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials

(2011) Julie E Ledgerwood et al.   LANCET INFECTIOUS DISEASES

Ferritin in the field of nanodevices

(2010) Ichiro Yamashita et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine

(2010) Davide Corti et al.   JOURNAL OF CLINICAL INVESTIGATION

Influenza Vaccines for the Future

(2010) Linda C. Lambert et al.   NEW ENGLAND JOURNAL OF MEDICINE

Induction of Broadly Neutralizing H1N1 Influenza Antibodies by Vaccination

(2010) C.-J. Wei et al.   SCIENCE

Cross-Neutralization of 1918 and 2009 Influenza Viruses: Role of Glycans in Viral Evolution and Vaccine Design

(2010) C.-J. Wei et al.   Science Translational Medicine

Far-red fluorescent tags for protein imaging in living tissues

(2009) Dmitry Shcherbo et al.   BIOCHEMICAL JOURNAL

Antibody Recognition of a Highly Conserved Influenza Virus Epitope

(2009) D. C. Ekiert et al.   SCIENCE